Follow the 딥노이드 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 딥노이드 has recorded 5 public disclosures. Market capitalisation: €45.4bn. The latest transaction was reported on 3 July 2026 (Other). Among the most active insiders: 김태규. Every trade is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Deepnoid is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions to enhance healthcare.